Children with autistic spectrum disorders. II: Parents are unable to distinguish secretin from placebo under double-blind conditions

Background: Standardised measures of behaviour have failed to detect short term improvement in children with autism following treatment with secretin. However, it is possible that standardised measures are insensitive to dimensions of child behaviour that are nonetheless detectable by parents. Aim:...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Archives of disease in childhood 2003-08, Vol.88 (8), p.737-739
Hauptverfasser:	Coplan, J, Souders, M C, Mulberg, A E, Belchic, J K, Wray, J, Jawad, A F, Gallagher, P R, Mitchell, R, Gerdes, M, Levy, S E
Format:	Artikel
Sprache:	eng
Schlagworte:	ASD Autism Autism Spectrum Disorders Autistic Disorder - drug therapy Autistic Disorder - psychology autistic spectrum disorder Behavior Biological and medical sciences Care and treatment CARS Child Child clinical studies Child Health Series Child, Preschool Childhood Autism Rating Scale Children & youth Clinical trials Communication and Symbolic Behavior Scale Cross-Over Studies CSBS Developmental disorders Double-Blind Method Families & family life Family Environment Female GBRS Gender Global Rating Scale Humans Hyperactivity Infantile autism Male Maternal & child health Medical sciences Parents Parents & parenting Parents - psychology Perceptions placebo Placebo Effect Psychology. Psychoanalysis. Psychiatry Psychopathology. Psychiatry Psychotropic Drugs - adverse effects Psychotropic Drugs - therapeutic use Racial Distribution Rating Scales Secretin Secretin - adverse effects Secretin - therapeutic use Treatment Outcome Validity
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!